Which undervalued stocks are under $5?

**Quick take 📉➡️📈** Many low-priced stocks appear “cheap” because they trade below $5, yet only a handful combine that price with positive earnings (P/E < 15) and reasonable market caps. From today’s screen, the following names stand out as potentially undervalued and worth a closer look: | Ticker | Company | Industry | Price (11/03/25) | P/E (TTM) | Market Cap ($bn) | |--------|---------|----------|------------------|-----------|------------------| | TEF | Telefónica S.A. | Telecom Services | $4.89 | –10.4 | 27.7 | | BBDO | Banco Bradesco (ADR) | Diversified Banks | $2.95 | 4.6 | 15.8 | | ABEV | Ambev S.A. | Beverages | $2.36 | 4.1 | 10.0 | | VFS | VinFast Auto | Auto Manufacturers | $3.18 | –2.3 | 7.4 | | B2G.A | B2Gold Corp. | Gold | $4.24 | –13.0 | 5.6 | | LPL | LG Display | Electronics | $5.00 | –10.9 | 5.0 | | GGB | Gerdau (Pref. ADR) | Steel | $3.48 | 9.2 | 4.7 | | ABEO | Abeona Therapeutics | Biotechnology | $4.78 | 4.3 | 0.25 | | NIVF | NewGenIVF Group | Biotechnology | $0.60 | 2.2 | 0.0013 | Why these matter: • **Valuation anchor:** Each trades below $5 and sports a trailing P/E under 15 (or negative but with sizable assets/restructuring potential). • **Sector mix:** While your focus is biotech, diversifying across sectors can reduce idiosyncratic risk. TEF, BBDO, and ABEV, for instance, generate positive cash flows and pay dividends—helpful for steady account growth. • **Biotech picks:** ABEO already meets your biotech-plus-value filter; NIVF is ultra-small-cap and highly volatile—handle with care and size positions to respect your ~$200 max-loss rule. • **Caveats:** Sub-$5 stocks often signal elevated risk—liquidity can be thin, bid/ask spreads wider, and delisting risks higher. Negative P/E values (e.g., TEF, VFS, LPL) actually mean current losses; view them as turnaround or asset-value plays, not classic “cheap” stocks. Actionable next steps 💡 1. **Deep-dive due diligence:** Focus on cash-flow trends, debt levels, and catalysts (e.g., cost-cutting, new product launches) rather than P/E alone. 2. **Build a watchlist with alerts:** Set price-based alerts (e.g., alert when ABEO breaks above $5 or falls below $4.50) to react quickly without constant screen-watching. 3. **Position sizing discipline:** For your $200 max-risk rule, cap position size so a -10% move equals ~$200—e.g., $2,000 notional on a $4 stock means ~500 shares. 4. **Exit strategy:** Pre-define stop-loss and profit-taking levels—especially vital for intraday biotech trades, where news flow can be abrupt. Curious to explore any of these names in depth—perhaps ABEO to see its trial pipeline, or TEF’s dividend safety? Which one aligns best with your current game plan? 🎯